@prefix dc: . @prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_head { this: np:hasAssertion dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_assertion; np:hasProvenance dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_provenance; np:hasPublicationInfo dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_publicationInfo; a np:Nanopublication . dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_assertion a np:Assertion . dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_provenance a np:Provenance . dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_publicationInfo a np:PublicationInfo . } dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_assertion { miriam-gene:2194 a ncit:C16612 . lld:C0678222 a ncit:C7057 . dgn-gda:DGN2ea086fc573fdae0cf9dbb396be2427b sio:SIO_000628 miriam-gene:2194, lld:C0678222; a sio:SIO_001121 . } dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_provenance { dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_assertion dc:description "[In summary, a) the molecular mechanism(s) contributing to Tzb resistance in our SKBR3/Tzb100 model appear to be clearly different to those previously reported as we found important transcriptional up-regulatory transcriptional changes in HER2 gene expression levels relative to parental cells; b) since FASN inhibition acts on HER2 gene expression via reduction of its transcription rate, Tzb-conditioned HER2-overexpressing breast cancer cells not only retain but further gain sensitivity to FASN inhibition; and c) transcriptional suppression of HER2 expression using FASN blockers may represent a new molecular strategy in the management of Tzb-resistant breast cancer disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:17786307; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP375623.RAAX0XPeAT7kkVCD-9KsXRdhJMHXBC_OcboLS6Z5_hfcQ130_publicationInfo { this: dc:created "2014-10-02T12:35:40+02:00"^^xsd:dateTime; dc:rights ; dc:rightsHolder dgn-void:IBIGroup; dc:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }